Pura Vida Investments, LLC Rigel Pharmaceuticals Inc Transaction History

Pura Vida Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 14, 2019	SELL	$2.0 - $2.65 $664,112 - $879,948	-332,056 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$2.08 - $3.36 $61,499 - $99,345	29,567 Added 9.77%	332,056 $764,000
Q3 2018 Nov 14, 2018	SELL	$2.6 - $3.59 $643,528 - $888,564	-247,511 Reduced 45.0%	302,489 $971,000
Q2 2018 Aug 14, 2018	SELL	$2.83 - $4.11 $97,813 - $142,053	-34,563 Reduced 5.91%	550,000 $1.56 Million
Q1 2018 May 14, 2018	SELL	$3.54 - $4.54 $70,800 - $90,800	-20,000 Reduced 3.31%	584,563 $0
Q4 2017 Feb 14, 2018	BUY	$3.23 - $4.3 $1.95 Million - $2.6 Million	604,563	604,563 $0

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $4.17B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.